https://orcid.org/0000-0001-8699-1412
References
- Skou ST, Mair FS, Fortin M, et al. Multimorbidity. Nat Rev Dis Primers. 2022 Jul 14;8(1):48.
- Murad MH. Clinical Practice Guidelines: A Primer on Development and Dissemination. Mayo Clin Proc. 2017 Mar;92(3):423–433.
- McAlister FA, van Diepen S, Padwal RS, et al. How evidence-based are the recommendations in evidence-based guidelines? PLoS Med. 2007 Aug;4(8):e250.
- Mangoni AA, Jansen PA, Jackson SH. Under-representation of older adults in pharmacokinetic and pharmacodynamic studies: a solvable problem? Expert Rev Clin Pharmacol. 2013 Jan;6(1):35–9.
- Roller-Wirnsberger R, Thurner B, Pucher C, et al. The clinical and therapeutic challenge of treating older patients in clinical practice. Br J Clin Pharmacol. 2020 Oct;86(10):1904–1911.
- Turk A, Wong G, Mahtani KR, et al. Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review. BMC Med. 2022 Aug 31;20(1):297.
- Benhamu B, Martin-Fontecha M, Vazquez-Villa H, et al. New Trends in Aging Drug Discovery. Biomedicines. 2022 Aug 18;10(8).
- Gordon AL, Witham MD, Henderson EJ, et al. Research into ageing and frailty. Future Healthc J. 2021 Jul;8(2):e237–e242.
- Sayer AA, Cruz-Jentoft A. Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing. 2022 Oct 6;51(10).
- Woodman RJ, Mangoni AA. A comprehensive review of machine learning algorithms and their application in geriatric medicine: present and future. Aging Clin Exp Res. 2023 Sep 8.